168 related articles for article (PubMed ID: 12207100)
21. Ultrafiltration failure in peritoneal dialysis. Causes and clinical consequences.
Smit W; Parikova A; Krediet RT
Minerva Urol Nefrol; 2005 Sep; 57(3):165-74. PubMed ID: 15986015
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis.
Gillerot G; Devuyst O
Clin Nephrol; 2003 Jul; 60(1):1-6. PubMed ID: 12872851
[TBL] [Abstract][Full Text] [Related]
23. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.
Miyata T; Devuyst O; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 2002 Feb; 61(2):375-86. PubMed ID: 11849377
[TBL] [Abstract][Full Text] [Related]
24. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
25. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
Fusshoeller A
Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
[TBL] [Abstract][Full Text] [Related]
26. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
[TBL] [Abstract][Full Text] [Related]
27. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
29. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
30. Determinants of peritoneal membrane function over time.
Davies SJ; Mushahar L; Yu Z; Lambie M
Semin Nephrol; 2011 Mar; 31(2):172-82. PubMed ID: 21439431
[TBL] [Abstract][Full Text] [Related]
31. The management of ultrafiltration failure in peritoneal dialysis.
Coles GA; Williams JD
Kidney Int Suppl; 1994 Dec; 48():S14-7. PubMed ID: 7700035
[No Abstract] [Full Text] [Related]
32. Peritoneal dialysis during peritonitis.
Rubin J; McFarland S; Hellems EW; Bower JD
Kidney Int; 1981 Mar; 19(3):460-4. PubMed ID: 7241884
[TBL] [Abstract][Full Text] [Related]
33. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
[TBL] [Abstract][Full Text] [Related]
34. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.
Kawaguchi Y; Kawanishi H; Mujais S; Topley N; Oreopoulos DG
Perit Dial Int; 2000; 20 Suppl 4():S43-55. PubMed ID: 11098928
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal changes in patients on long-term peritoneal dialysis.
Krediet RT; Struijk DG
Nat Rev Nephrol; 2013 Jul; 9(7):419-29. PubMed ID: 23670085
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal solute transport and inflammation.
Davies SJ
Am J Kidney Dis; 2014 Dec; 64(6):978-86. PubMed ID: 25176170
[TBL] [Abstract][Full Text] [Related]
37. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
[TBL] [Abstract][Full Text] [Related]
38. Surgical peritonitis in patients on peritoneal dialysis.
Shrestha BM; Brown P; Wilkie M
Perit Dial Int; 2008; 28(4):331-4. PubMed ID: 18556371
[TBL] [Abstract][Full Text] [Related]
39. Association between peritoneal protein excretion, peritonitis and D/P phosphate, in patients on peritoneal dialysis.
Rodríguez-García VH; López-Guerra EA; Rodríguez-Castellanos FE
Nefrologia; 2013; 33(2):204-13. PubMed ID: 23511756
[TBL] [Abstract][Full Text] [Related]
40. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
Ekim M; Fitöz S; Yagmurlu A; Ensari A; Yüksel S; Acar B; Ozçakar ZB; Kendirli T; Bingöler B; Yalçinkaya F
Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
